Skip to main content
Log in

Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In the present study, we hypothesized that endotoxemia produces metalloendopeptidase (MEPD)-dependent generation of endothelin-1 (ET-1) and alters NOS expression correlating with p38-mitogen-activated protein kinase (MAPK) phosphorylation in thoracic aorta. Male Sprague-Dawley rats (350–400 g) were subjected to two groups randomly; sham-treated (N= 10) and lipopolysaccharide (LPS)-treated (N= 10) (E. coli LPS 2 mg/kg bolus + 2 mg/kg infusion for 30 min). The animals in each group were further subdivided into vehicle and MEPD inhibitor phosphoramidon (1 mg/kg bolus, PHOS)-treated groups. LPS produces a significant decrease in mean arterial pressure (MAP) at 2 h post endotoxemia that was blocked by PHOS. PHOS attenuated LPS-induced increase in tumor necrosis factor-alpha (TNF-α) concentration at 2- and 24 h post-LPS administration. LPS significantly elevated plasma concentrations of ET-1 at 2- and 24 h post endotoxemia. An upregulated preproET-1 expression following both LPS and MEPD inhibition was observed in thoracic aorta at 2 h post treatment. PHOS effectively blocked conversion of preproET-1 to ET-1 in thoracic aorta locally at 24 h post treatment in endotoxic rats. PHOS inhibited LPS-induced upregulation of inducible NOS (iNOS), downregulation of endothelial NOS (eNOS) and elevation of NO byproducts (NO x ) in thoracic aorta. PHOS also blocked LPS-induced upregulated p38-MAPK phosphorylation in thoracic aorta at 24 h post endotoxemia. The data revealed that LPS induces MEPD-sensitive inflammatory response syndrome (SIRS) at 2- and 24 h post endotoxemia. We concluded that inhibition of MEPD not only decreases the levels of ET-1 but also simultaneously downregulates protein expression of iNOS and phosphorylated p38-MAPK while increasing eNOS in thoracic aorta during SIRS in endotoxemia. We suggest that MEPD-dependent ET-1 and NO mechanisms may be involved in endotoxemia-induced altered p38-MAPK phosphorylation. (Mol Cell Biochem 265: 47–56, 2004)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Glauser MP, Zannetti G, Baumgartner J-D, Cohen J: Septic shock: patho-genesis. Lancet 338:732–736, 1991

    Google Scholar 

  2. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parillo JE: The cardiovascular response of normal humans to the administration of endotoxin. New Engl J Med 321: 280–287, 1989

    Google Scholar 

  3. Nakaki T, Otsuka Y, Nakayama M, Kato R: Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur J Pharmacol 219: 311–318, 1992

    Google Scholar 

  4. Sharma AC, Sam II AD, Alden KJ, Moore S, Law WR, Ferguson JL: Central versus peripheral mediation of naloxone's perfusion effects in endotoxic rats. Shock 14: 441–446, 2000

    Google Scholar 

  5. Olsson LE, Wheeler MA, Secca WC, Weiss RM: Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder. J Pharmacol Exp Ther 284: 1203–1208, 1998

    Google Scholar 

  6. Salter M, Knowles RG, Moncada S: Widespread tissue distribution, species distribution and changes in activity of Ca 2 +-dependent and Ca 2 +-independent nitric oxide synthesis. FEBS Lett 291: 145–149, 1991.

    Google Scholar 

  7. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M: Endotoxin and cy-tokines induce direct cardiodepressive effects in mammalian cardiomy-ocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28: 1631–1639, 1996

    Google Scholar 

  8. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayishi Y, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent, vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988

    Google Scholar 

  9. Guha M and Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 13: 85–94, 2001

    Google Scholar 

  10. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29: 1469–1477, 1997

    Google Scholar 

  11. Gupta A, Sharma AC: Metalloendopeptidase inhibition regulates phos-phorylation of p38-mitogen activated protein kinase and nitric oxide synthase in heart following endotoxemia. Shock 20: 375–381, 2003

    Google Scholar 

  12. Bogoyevitch MA, Ketterman AJ, Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270: 29710–29717, 1995

    Google Scholar 

  13. Clerk A, Bogoyevitch MA, Anderson MB, Sugden PH: Differential ac-tivation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269: 32848–32857, 1994

    Google Scholar 

  14. Liu W, Kato M, Itoigawa M, Murakami H, Yajima M, Wu J, Ishikawa N, Nakashima I: Distinct involvement of NF-ê Band p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J Cell Biochem 83: 271–280, 2001

    Google Scholar 

  15. Tracey, WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmaco-logical evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Therapeut 272: 1011–1015, 1995

    Google Scholar 

  16. Pollack JS, Nakane M, Buttery LDK, Martinez A, Springdall JM, Polak JM, Forstermann U, Murad F: Characterization and localization of en-dothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265: C1379–C1387, 1993

    Google Scholar 

  17. Mazzocchi G, Albertin G, Nussdorfer GG: Adrenomedullin (ADM), acting through ADM (22-52)-sensitive receptors, is involved in the endotoxin-induced hypotension in rats. Life Sci 66(15): 1445–1450, 2000

    Google Scholar 

  18. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and what we do not know about cytokine regulation. Crit Care Med 24: 163–172, 1996

    Google Scholar 

  19. Cadenas S, Cadenas AM: Fighting the stranger-antioxidant protection against endotoxin activity. Toxicology 180: 45–63, 2002

    Google Scholar 

  20. Suda H, Aoyagi T, Takeuchi T, Umezawa H: A thermolysin inhibitor produced by actinomycetes: Phosphoramidon. J Antibiotics 26: 621–623, 1973

    Google Scholar 

  21. Ohnaka K, Takayanagi R, Nishikawa M, Haji M, Nawata H: Purifi-cation and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. J Biol Chem 268: 26759–26766, 1993

    Google Scholar 

  22. Turner AJ, Murphy LJ: Molecular pharmacology of endothelin convert-ing enzymes. Biochem Pharmacol 51: 91–102, 1996

    Google Scholar 

  23. Arriero MM, de la Pinta JC, Escribano M, Celdran A, Munuoz-Alameda L, Garcia-Canete J, Jimenez MA, Casado S, Farre J, Lopez-Farre A: Aspirin prevents Escherichia coli lipopolysaccharide-and Staphylo-coccus aureus-induced downregulation of endothelial nitric oxide syn-thase expression in guinea pig pericardial tissue. Circ Res 90, 719–727, 2002

    Google Scholar 

  24. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A: Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773–775, 2003

    Google Scholar 

  25. Loke KE, McConnell PI, Tuzman JM, Shensely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, Hintze TH: Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84: 840–845, 1999

    Google Scholar 

  26. DePlaen IG, Qu XW, Wang H, Tan XD, Wang L, Han XB, Rozenfeld RA, Hsueh W: Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. Immunology 106: 577–583, 2002

    Google Scholar 

  27. LaPointe MC, Isenovic E: Interleukin-1beta regulation of inducible ni-tric oxide synthase and cyclooxygenase-2 involves the p42/p44 and p38 MPAK signaling pathways in cardiac myocytes. Hypertension 33: 276–282, 1999

    Google Scholar 

  28. McKenna TM, Li S, Tao S: PKC mediates LPS-and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 269: H1891–H1898, 1995

    Google Scholar 

  29. Kubo T, Ibusuku T, Chiba S, Kambe T, Fukumori R: Mitogen-activated protein kinase activity regulation of angiotensin and endothelin systems in vascular smooth muscle cells. Eur J Pharmacol 411: 27–34, 2001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, A., Sharma, A.C. Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases. Mol Cell Biochem 265, 47–56 (2004). https://doi.org/10.1023/B:MCBI.0000044314.29395.fb

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000044314.29395.fb

Navigation